Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Anagnostou

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 27, 2016
What do we mean by oral tolerance?K Anagnostou, A Clark
The British Journal of Dermatology|January 16, 2016
Author response to Marrs et al., Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisalK Anagnostou, A Clark
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancerValsamo K Anagnostou, Julie R Brahmer
Allergy|July 11, 2007
Cashew nut causes more severe reactions than peanut: case-matched comparison in 141 childrenA T Clark, K Anagnostou, P W Ewan
Applied Clinical Informatics|May 10, 2011
Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institutionTaxiarchis Botsis, Valsamo K Anagnostou, Gunnar Hartvigsen, et al.
Cancer Informatics|May 29, 2010
Modeling prognostic factors in resectable pancreatic adenocarcinomasTaxiarchis Botsis, Valsamo K Anagnostou, Gunnar Hartvigsen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 19, 2011
Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcomeK Anagnostou, A Clark, Y King, et al.
Virchows Archiv : an International Journal of Pathology|December 17, 2010
Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patientsValsamo K Anagnostou, Dina G Tiniakos, Marianthi Fotinou, et al.
Allergy|February 20, 2009
Successful oral tolerance induction in severe peanut allergyA T Clark, S Islam, Y King, et al.
Connecticut Medicine|March 8, 2014
A longitudinal, collaborative, practice-based learning and improvement model to improve post-discharge heart failure outcomesValsamo K Anagnostou, Grant Bailey, Edward Sze, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 27, 2016
What do we mean by oral tolerance?K Anagnostou, A Clark
The British Journal of Dermatology|January 16, 2016
Author response to Marrs et al., Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisalK Anagnostou, A Clark
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancerValsamo K Anagnostou, Julie R Brahmer
Allergy|July 11, 2007
Cashew nut causes more severe reactions than peanut: case-matched comparison in 141 childrenA T Clark, K Anagnostou, P W Ewan
Applied Clinical Informatics|May 10, 2011
Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institutionTaxiarchis Botsis, Valsamo K Anagnostou, Gunnar Hartvigsen, et al.
Cancer Informatics|May 29, 2010
Modeling prognostic factors in resectable pancreatic adenocarcinomasTaxiarchis Botsis, Valsamo K Anagnostou, Gunnar Hartvigsen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 19, 2011
Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcomeK Anagnostou, A Clark, Y King, et al.
Virchows Archiv : an International Journal of Pathology|December 17, 2010
Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patientsValsamo K Anagnostou, Dina G Tiniakos, Marianthi Fotinou, et al.
Allergy|February 20, 2009
Successful oral tolerance induction in severe peanut allergyA T Clark, S Islam, Y King, et al.
Connecticut Medicine|March 8, 2014
A longitudinal, collaborative, practice-based learning and improvement model to improve post-discharge heart failure outcomesValsamo K Anagnostou, Grant Bailey, Edward Sze, et al.
Pageof 3